Suchergebnisse - "Remission Induction"

PubPharm (354)

101

Clinical trial of low-dose decitabine (DAC) administered alone or in combination with the valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for standard chemotherapy : Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for induction chemotherapy - DECIDER Trial

enthalten in: WHO International Clinical Trials Registry Platform | 2020

102

Administration of amifostine in the stage of remission induction can benefit the patients with hematological malignancy in autologous stem cell transplantation : a retrospective study

enthalten in: Translational cancer research | 2020

von Wu, M. | Wu, K. | Chen, P. | +2

103

Changes in body weight and serum liver tests associated with parenteral nutrition compared with no parenteral nutrition in patients with acute myeloid leukemia during remission induction treatment

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2020

von van Lieshout, R. | Tick, L. | Dieleman, J. | +7

104

Reduction of biologics in rheumatoid arthritis: a systematic review and meta-analysis

enthalten in: Rheumatology international | 2020

von Vasconcelos, L. | Silva, M. | Galvao, T.

105

Reduction of biologics in rheumatoid arthritis: a systematic review and meta-analysis

enthalten in: Rheumatology international | 2020

von Vasconcelos, L. | Silva, M. | Galvao, T.

106

Reduction of biologics in rheumatoid arthritis: a systematic review and meta-analysis

enthalten in: Rheumatology international | 2020

von Vasconcelos, L. | Silva, M. | Galvao, T.

107

Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide

enthalten in: Modern rheumatology case reports | 2020

von Ohmura, S. | Uehara, K. | Yamabe, T. | +3

108

Update Nierenzellkarzinom

enthalten in: Best practice Onkologie | 2020

von Püllen, L. | Grimm, M. | Grünwald, V.

109

Update Nierenzellkarzinom

enthalten in: Best Practice Onkologie | 2020

von Püllen, L. | Grimm, M. | Grünwald, V.

110

Update Nierenzellkarzinom

enthalten in: Best Practice Onkologie | 2020

von Püllen, L. | Grimm, M. | Grünwald, V.